The Immun Status Changes Due to Intermittent Fasting
The Effect of Intermittent Fasting on Immune System
1 other identifier
interventional
20
1 country
1
Brief Summary
Positive effects of calorie restriction on quality of life and diseases are reported. Intermittent fasting, one of the calorie restriction methods, has been shown to be beneficial for health with many metabolic effects, not just calorie restriction. Preclinical studies show the disease-modifying effects of intermittent fasting in animal models on a wide variety of chronic disorders, including obesity, diabetes, cardiovascular disease, cancers, and neurodegenerative brain diseases. There are very few studies evaluating the effects of intermittent fasting on the immune system, and only TNFα, IL6 and IL10 cytokines were evaluated in these studies to evaluate the immune system. In this study, we aimed to evaluate the conditions of inflammatory markers in peripheral blood before and after intermittent fasting period in overweight volunteers with a Body Mass Index between 25 and 30. Volunteers will have intermittent fasting for 3 weeks, which conforms to the 16-hour fasting and 8-hour meal format.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 13, 2021
CompletedFirst Submitted
Initial submission to the registry
May 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2021
CompletedFirst Posted
Study publicly available on registry
May 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2021
CompletedJune 2, 2022
June 1, 2022
22 days
May 5, 2021
June 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cytokine levels
IL1, IL6, TNFα, IL10 cytokine levels
3 weeks
Secondary Outcomes (1)
Demographic values
3 weeks
Study Arms (1)
Intermittent fasting
EXPERIMENTALInterventions
30 overweight male volunteers who will have 3 weeks intermittent fasting which has 16 hours fasting and 8 hours eating in a day period.
Eligibility Criteria
You may qualify if:
- Bady mass index should be between 25-30
- Male
You may not qualify if:
- Diabetes patients,
- Immune deficiency history,
- Cancer patients,
- Individuals who did not agree to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Training and Research Hospital
Istanbul, 34098, Turkey (Türkiye)
Related Publications (3)
Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med. 1997 Oct 2;337(14):986-94. doi: 10.1056/NEJM199710023371407. No abstract available.
PMID: 9309105BACKGROUNDPanda S. Circadian physiology of metabolism. Science. 2016 Nov 25;354(6315):1008-1015. doi: 10.1126/science.aah4967.
PMID: 27885007BACKGROUNDDi Francesco A, Di Germanio C, Bernier M, de Cabo R. A time to fast. Science. 2018 Nov 16;362(6416):770-775. doi: 10.1126/science.aau2095.
PMID: 30442801BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ufuk O Idiz, Assoc.Prof.
Istanbul Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Measuring the level of IL1, IL6, TNFα, IL10 cytokines before and after the 3 weeks intermittent fasting period for 30 overweight volunteers
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. MD
Study Record Dates
First Submitted
May 5, 2021
First Posted
May 7, 2021
Study Start
April 13, 2021
Primary Completion
May 5, 2021
Study Completion
June 15, 2021
Last Updated
June 2, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share
If the study complete, we could share